Celecoxib inhibits interleukin-12 alphabeta and beta2 folding and secretion by a novel COX2-independent mechanism involving chaperones of the endoplasmic reticulum.


Autoria(s): Vandenbroeck, Koen; Alloza, Iraide; Baxter, A.; Chen, Q.; Matthiesen, R.
Data(s)

01/02/2006

Identificador

http://pure.qub.ac.uk/portal/en/publications/celecoxib-inhibits-interleukin12-alphabeta-and-beta2-folding-and-secretion-by-a-novel-cox2independent-mechanism-involving-chaperones-of-the-endoplasmic-reticulum(b64765be-6133-44e5-a283-dc5fc0b946f1).html

http://dx.doi.org/10.1124/mol.105.020669

http://www.scopus.com/inward/record.url?scp=33645813833&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Vandenbroeck , K , Alloza , I , Baxter , A , Chen , Q & Matthiesen , R 2006 , ' Celecoxib inhibits interleukin-12 alphabeta and beta2 folding and secretion by a novel COX2-independent mechanism involving chaperones of the endoplasmic reticulum. ' Molecular Pharmacology , vol 69(5) , no. 5 , pp. 1579-1587 . DOI: 10.1124/mol.105.020669

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/3000/3004 #Pharmacology
Tipo

article